An April 24 news article highlighted the benefits of HPV vaccination for boys and men, sparking debate about the vaccine’s safety and effectiveness. The article described new research suggesting that vaccination may reduce the risk of HPV-related cancers among males by nearly half. Some users discussed how the vaccine has been discouraged in many religious communities by claims that it encourages sexual risk behaviors; these claims are false. Although many comments were supportive of HPV vaccination, some expressed concerns about safety and accused the media of spreading propaganda.
Recommendation
Myths and misconceptions about HPV vaccination have contributed to hesitancy and vaccination rates in the U.S. remaining below global targets. Health communicators may explain that HPV affects 8 in 10 sexually active people, is the leading cause of cervical cancer, and contributes to several other cancers. Messaging may explain that HPV vaccination is highly effective, reducing cervical cancer risk by around 90 percent. A recent study also found that vaccinated men had a 46 percent lower risk of developing HPV related cancers. Emphasizing that HPV vaccination is most effective when administered before exposure to the virus is recommended, as is highlighting that people with HPV can transmit the virus to partners and may develop HPV-related cancers, including anal, penile, and throat cancers. Communicators may also note that the HPV vaccine is very safe, is recommended for all adolescents, and is available for individuals ages 9 through 45.
Fact-checking sources: American Sexual Health Association, PAHO, Public Good Projects
Communication resources: Share this resource about HPV and the HPV vaccine
